Standout Papers

Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neu... 2002 2026 2010 2018 596
  1. Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED] (2002)
    Douglas S. Goodin, Elliot M. Frohman et al. Neurology

Immediate Impact

1 by Nobel laureates 6 from Science/Nature 83 standout
Sub-graph 1 of 20

Citing Papers

Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy
2024 Standout
Multiple sclerosis
2023 Standout
5 intermediate papers

Works of Gerald Garmany being referenced

Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
2002 Standout

Author Peers

Author Last Decade Papers Cites
Gerald Garmany 71 63 501 190 168 10 723
Nieves Téllez 42 48 501 196 163 10 583
Alexandra Degenhardt 41 95 641 236 218 10 751
Mark Rametta 55 71 507 126 144 17 666
Trevor Pickersgill 64 69 644 225 151 26 801
Marc Coustans 32 74 669 322 193 10 845
CH Polman 97 71 621 175 164 24 765
Maria Lopez-Bresnahan 31 52 410 212 92 15 674
T. Pickersgill 27 60 574 249 191 12 717
Laura Vacchi 55 94 430 135 101 18 698
Agnès Fromont 51 87 410 185 141 25 765

All Works

Loading papers...

Rankless by CCL
2026